Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description: This dashboard presents selected data that are relevant for monitoring the impacts of COVID-19 on economic activity in Canada. It includes data on a range of monthly indicators—real GDP, consumer prices, the unemployment rate, merchandise exports and imports, retail sales, hours worked and manufacturing sales—as well as monthly data on aircraft movements, railway carloadings, and travel between Canada and other countries.

Estimates are presented from January 2019 to the current reference month for each data series. The information will be updated continuously as new data becomes available, and additional series may be added to the dashboard as circumstances warrant.

To support the analysis of time series movements in the data, the dashboard reports changes in each series on both a month-over-month and year-over-year basis. For most of the variables reported, information on cumulative changes in the data both prior and subsequent to the end of 2019 is also presented by indexing the level estimates to December 2019, as depicted in the accompanying charts.

Description: Number and percentage of Canadians aged 20 to 79 with diabetes, prediabetes, as well as diabetes awareness, pharmaceutical treatment and glycemic control among those with diabetes by age group and sex.

Description:

Number and percentage of persons having been diagnosed with arthritis, by age group and sex.

Description:

Number and percentage of persons having been diagnosed with diabetes, by age group and sex.

Description:

Number and percentage of persons having been diagnosed with asthma, by age group and sex.

Description:

Number and percentage of persons having been diagnosed with high blood pressure, by age group and sex.

Description:

Number and percentage of persons having been diagnosed with a chronic obstructive pulmonary disease (COPD), by age group and sex.

Description: Number and percentage of adults who reported being overweight or obese, by age group and sex.

Description:

Number and percentage of youth who reported being overweight or obese, by sex.

Description:

Number and percentage of persons who reported having their last influenza immunization in the past 12 months, by age group and sex.

Description: Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.

Description:

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Description: Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description:

This document provides descriptive results of the muscle and bone density of the tibia. Descriptive results for lower limb muscle power and force are also presented.

Description:

Hypertension is a common condition experienced by close to one-quarter of the adult population in Canada. There is evidence that this condition or the medications used to treat it may lead to hearing health problems. The purpose of this study is to quantify associations between hypertension and hearing health problems—defined as having hearing loss, tinnitus or both conditions for adults aged 19 to 79 years. Data from cycles 3 (2012 to 2013) and 4 (2014 to 2015) of the Canadian Health Measures Survey are used.

Description:

This infographic provides information on the prevalence of hearing loss, tinnitus, or both conditions among Canadian adults. The prevalence of each condition is presented by sex and age group. Also included is the proportion who are unaware of their hearing loss.

Description:

This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.

Description:

Cancer incidence rates have been shown to vary by ethnicity, and the increasing awareness of and interest in reporting ethnic health inequalities have been growing internationally. The objective of this study was to assess cancer incidence and mortality rates by ethnicity in Canada. The study used the 2006 Canadian Census Health and Environment Cohort, linked to the Canadian Cancer Registry and the Canadian Vital Statistics-Death Database, to determine cancer cases and mortality from 2006 to 2016. Ethnicity was categorized as non-Indigenous North American (NINA); European; Caribbean; Latin, Central and South American (LCSA); African; East Asian; South Asian; and West Central Asian and Middle Eastern.

Description:

With data from the 2019 Canadian Community Health Survey, this study assessed the use of and exposure to handheld laser devices by Canadians and the potential associated health risks. In addition to the prevalence of handheld laser exposure or use, the frequency and type of injury sustained, and whether the injury was the result of personal use or someone else's use, the study also determined the type of handheld laser device being used and where the device was obtained.

Description:

This document examines the functional limitations-physical, emotional and social-related to the most common types of diabetes and the conditions that result from the disease. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with diabetes affects day-to-day functioning.

Description:

This document examines the functional limitations - physical, emotional and social -experienced by patients at the time of diagnosis of cancer and as they undergo various treatments, remission, and palliative and terminal care. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with cancer affects day-to-day functioning.

Description:

The Cancer Record is a newsletter for cancer registries in Canada. Its main purpose is to improve the quality and consistency of data submitted to the Canadian Cancer Registry. The goals of the newsletter are to establish and continue communication among cancer registry personnel, establish a mechanism for identifying and resolving coding or reporting inconsistencies in the national registry and update cancer registries regarding the continued development at the national level.

Description: The purpose of the Survey on Living with Chronic Diseases in Canada (SLCDC) is to provide information on the impact of chronic disease on individuals, as well as how people with chronic disease manage their health condition.

Description: The purpose of the Survey on Living with Neurological Conditions in Canada is to collect new information about Canadians' experiences with chronic neurological conditions. The survey will report on various factors that impact on health for individuals living with these conditions, their families and caregivers.

Description: This survey collects data on the prevalence of several neurological conditions in long-term care facilities.

Description: The objectives of the BCPCHC Survey are: - To provide more information on how people manage their chronic conditions; - To identify barriers to care for those living with chronic conditions including economic and travel related barriers; - To identify barriers to self-management of chronic conditions.

Description: The data contain detailed confirmed cases of coronavirus disease (COVID-19) in Canada, which is compiled by the Public Health Agency of Canada, with the contribution from provincial and territorial Health ministries.

Description: This survey was conducted to collect accident information in Canada.

Description: The Canadian Cancer Registry (CCR) is a population based registry that includes data collected and reported to Statistics Canada (StatCan) by each provincial/territorial cancer registry (PTCR). The person based CCR collects information about each new primary cancer diagnosed among Canadian residents since 1992. The objective is to produce standardized and comparable incidence data that can be used to assist and support health planners and decision-makers to: identify risk factors; plan, monitor and evaluate cancer screening, treatment and control programs; and conduct research.